Amryt Pharma (Amryt Pharma) Cyclically Adjusted PS Ratio : (As of Jun. 01, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Amryt Pharma Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation

Amryt Pharma Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Amryt Pharma's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amryt Pharma Cyclically Adjusted PS Ratio Chart

Amryt Pharma Annual Data

Trend

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

Amryt Pharma Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Amryt Pharma's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Amryt Pharma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amryt Pharma's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amryt Pharma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Amryt Pharma's Cyclically Adjusted PS Ratio falls into.

Amryt Pharma Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Amryt Pharma's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec21 is calculated as:

For example, Amryt Pharma's adjusted Revenue per Share data for the fiscal year that ended in Dec21 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Dec21 (Change)	*	Current CPI (Dec21)
	=	4.505	/	114.7000	*	114.7000
	=	4.505

Current CPI (Dec21) = 114.7000.

Amryt Pharma Annual Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201203	0.000	95.400	0.000
201303	0.000	97.800	0.000
201403	0.000	99.300	0.000
201503	0.000	99.600	0.000
201612	0.261	102.200	0.293
201712	2.062	105.000	2.252
201812	1.866	107.100	1.998
201912	3.830	108.500	4.049
202012	5.757	109.400	6.036
202112	4.505	114.700	4.505

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Amryt Pharma (NAS:AMYT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Amryt Pharma Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Amryt Pharma's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Amryt Pharma (Amryt Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amryt Pharma PLC (NAS:AMYT) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

196 High Road, Dept 920A, Wood Green, London, GBR, N22 8HH

Website

http://www.amrytpharma.com

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).